In patients with decreased LVEF or left ventricular hypertrophy, angiotensin converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of post-operative AF recurrence (36). This evidence concerns the gene ACE and left ventricular hypertrophy.